← Back to Clinical Trials
Recruiting NCT05073276

NCT05073276 Non- Vs Partial Controlled Weightbearing After Multiple Knee Ligament Reconstruction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05073276
Status Recruiting
Phase
Sponsor Twin Cities Orthopedics
Condition Knee Injuries
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2020-01-01
Primary Completion 2026-01

Eligibility & Interventions

Sex All sexes
Min Age 14 Years
Max Age 59 Years
Study Type INTERVENTIONAL
Interventions
Physical Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2020-01-01 with a primary completion date of 2026-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is a prospective randomized controlled trial with the purpose to determine if patients undergoing isolated posterior cruciate ligament (PCL) reconstruction, or isolated medial collateral ligament (MCL) reconstruction, or combined PCL, anterior cruciate ligament (ACL), fibular collateral ligament (FCL), posterolateral corner (PLC), and MCL reconstructions (or any combination of multiple ligaments) can safely begin partial controlled weightbearing for the first six weeks after surgery.

Eligibility Criteria

Inclusion Criteria: * ≥ 14 years old, \<60 * Reconstruction of PCL alone * Reconstruction of MCL alone * Reconstruction of combined multiligament injuries (PCL+ (FCL, PLC, ACL, MCL)) * Reconstruction of multiligament injuries (ACL+MCL) * Males or females * Is willing and able to comply with the clinical trial plan and able to understand and sign the Patient Informed Consent Form. Exclusion Criteria: * \< 14 years old * \>60 years old * Pregnant * Revision PCL reconstructions * Previous or concurrent vascular injury (vascular bypass procedure) * Associated fractures requiring concurrent surgery * Concurrent meniscal root or radial repair surgery

Contact & Investigator

Central Contact

Becky McGaver

✉ research@tcomn.com

📞 952-456-7136

Principal Investigator

Robert F LaPrade, MD, PhD

PRINCIPAL INVESTIGATOR

Twin Cities Orthopedics

Frequently Asked Questions

Who can join the NCT05073276 clinical trial?

This trial is open to participants of all sexes, aged 14 Years or older, up to 59 Years, studying Knee Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05073276 currently recruiting?

Yes, NCT05073276 is actively recruiting participants. Contact the research team at research@tcomn.com for enrollment information.

Where is the NCT05073276 trial being conducted?

This trial is being conducted at Edina, United States.

Who is sponsoring the NCT05073276 clinical trial?

NCT05073276 is sponsored by Twin Cities Orthopedics. The principal investigator is Robert F LaPrade, MD, PhD at Twin Cities Orthopedics. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology